S&P Global Inc. (SPGI) CEO Martina Cheung presents at Bernstein's 41st Annual Strategic Decisions Conference (Transcript)…
Tag: Presents
Exxon Mobil Corporation (XOM) Presents at Bernstein 41st Annual Strategic Decisions Conference (Transcript)
Exxon Mobil Corporation (XOM) Presents at Bernstein 41st Annual Strategic Decisions Conference (Transcript) #Exxon #Mobil #Corporation…
Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025
Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in…
Lam Research Corporation (LRCX) CEO Tim Archer Presents at Bernstein 41st Annual Strategic Decisions Conference (Transcript)
Lam Research Corporation (LRCX) CEO Tim Archer Presents at Bernstein 41st Annual Strategic Decisions Conference (Transcript)…
Honeywell International Inc. (HON) Presents at Wolfe Research 2025 Global Transportation and Industrials Conference (Transcript)
Honeywell International Inc. (HON) Presents at Wolfe Research 2025 Global Transportation and Industrials Conference (Transcript) #Honeywell…
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Soci
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial…
Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure
Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with…
Visa Inc. (V) CEO Ryan McInerney Presents at Annual JPMorgan Global Technology, Media and Communications Conference (Transcript)
Visa Inc. (V) CEO Ryan McInerney Presents at Annual JPMorgan Global Technology, Media and Communications Conference…
Array Technologies: Stabilization Presents A Great Risk-To-Reward Opportunity
Array Technologies: Stabilization Presents A Great Risk-To-Reward Opportunity #Array #Technologies #Stabilization #Presents #Great #RiskToReward #Opportunity
Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer Research (AACR) Annual Meeting
Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer…
Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting
Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small…
Delta Air Lines Q1 Preview: Cheaper Oil Presents A Strong Tailwind
Delta Air Lines Q1 Preview: Cheaper Oil Presents A Strong Tailwind #Delta #Air #Lines #Preview #Cheaper…
Biohaven Presents Data Across Innovative Neuroscience Portfolio at the 2025 American Academy of Neurology (AAN) Annual Meeting
Biohaven Presents Data Across Innovative Neuroscience Portfolio at the 2025 American Academy of Neurology (AAN) Annual…
Beam Therapeutics Presents Additional Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at 2025 Alpha-1 Foundation 7th Global Research Conference and 10th Patient Congress
Beam Therapeutics Presents Additional Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at 2025 Alpha-1 Foundation…
Alnylam Presents New Data from the HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM) at the American College of Cardiology's Annual Scientific Sess
Alnylam Presents New Data from the HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR…
Mexico's Ongoing Rate Reducing Mission Presents Opportunity
Mexico's Ongoing Rate Reducing Mission Presents Opportunity #Mexico039s #Ongoing #Rate #Reducing #Mission #Presents #Opportunity
Correction: Equinor presents 2024 Annual report
Correction: Equinor presents 2024 Annual report#Correction #Equinor #presents #Annual #report
Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical &…